Jeena Sikho Lifecare (NSE:JSLL) ROC (Joel Greenblatt) %: 94.45% (As of Mar. 2026) — 40% Above Median


NSE:JSLL Jeena Sikho Lifecare Ltd NSE:JSLL
91 GF Score
Price ₹602.25
GF Value ₹771.54
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Jeena Sikho Lifecare ROC (Joel Greenblatt) %?

Jeena Sikho Lifecare NSE:JSLL +3.81% 91 ROC (Joel Greenblatt) % is 94.45% as of Mar. 2026, which is 40% above its 10-year median of 67.49. GuruFocus rates NSE:JSLL with a GF Score™ of 91/100 and a GF Value™ of ₹771.54 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 670 Healthcare Providers & Services companies, Jeena Sikho Lifecare ranks better than 90.45% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Jeena Sikho Lifecare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 94.45%.

The historical rank and industry rank for Jeena Sikho Lifecare's ROC (Joel Greenblatt) % or its related term are showing as below:

NSE:JSLL' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 39.3   Med: 67.49   Max: 134.7
Current: 129.12

During the past 8 years, Jeena Sikho Lifecare's highest ROC (Joel Greenblatt) % was 134.70%. The lowest was 39.30%. And the median was 67.49%.

NSE:JSLL's ROC (Joel Greenblatt) % is ranked better than
90.45% of 670 companies
in the Healthcare Providers & Services industry
Industry Median: 12.47 vs NSE:JSLL: 129.12

Jeena Sikho Lifecare's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 17.00% per year.


Jeena Sikho Lifecare  (NSE:JSLL) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Jeena Sikho Lifecare ROC (Joel Greenblatt) % Related Terms


Jeena Sikho Lifecare ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Jeena Sikho Lifecare's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jeena Sikho Lifecare ROC (Joel Greenblatt) % Chart

Jeena Sikho Lifecare Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial 51.68 75.89 90.95 76.53 134.70

Jeena Sikho Lifecare Quarterly Data
Mar19 Mar20 Mar21 Sep21 Mar22 Mar23 Mar24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 79.79 151.27 127.72 141.49 94.45

NSE:JSLL vs HCA, THC, DVA: ROC (Joel Greenblatt) % Comparison

For the Medical Care Facilities subindustry, Jeena Sikho Lifecare's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jeena Sikho Lifecare ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Jeena Sikho Lifecare's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Jeena Sikho Lifecare's ROC (Joel Greenblatt) % falls into.


NSE:JSLL
91GF Score
Jeena Sikho Lifecare Ltd NSE:JSLL
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jeena Sikho Lifecare ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(699.291 + 202.182 + 240.816) - (312.97 + 0 + 421.378)
=407.941

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Jeena Sikho Lifecare for the quarter that ended in Mar. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2598.124/( ( (0 + max(0, 0)) + (2342.808 + max(407.941, 0)) )/ 1 )
=2598.124/( ( 0 + 2750.749 )/ 1 )
=2598.124/2750.749
=94.45 %

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of 94.45% mean?
Jeena Sikho Lifecare (NSE:JSLL) has a ROC (Joel Greenblatt) % of 94.45% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Jeena Sikho Lifecare and its competitors. This is 40% above median its historical median of 67.49. Over the past decade, Jeena Sikho Lifecare's ROC (Joel Greenblatt) % has ranged from 39.30 to 134.70. According to the industry distribution chart, Jeena Sikho Lifecare ranks #64 out of 670 companies in the Healthcare Providers & Services industry, placing it in the top 9.6%.
Is Jeena Sikho Lifecare's ROC (Joel Greenblatt) % too high?
Jeena Sikho Lifecare's current ROC (Joel Greenblatt) % of 94.45% is 40% above median its 10-year median of 67.49. Over the past 10 years, this metric has ranged from a low of 39.30 to a high of 134.70. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.47. Jeena Sikho Lifecare's value of 94.45% is 657.4% above this industry median. Based on the distribution chart, Jeena Sikho Lifecare ranks #64 out of 670 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Jeena Sikho Lifecare has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jeena Sikho Lifecare's ROC (Joel Greenblatt) % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jeena Sikho Lifecare ranks #64 out of 670 companies for ROC (Joel Greenblatt) %. This places Jeena Sikho Lifecare in the top 10% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 12.47. Jeena Sikho Lifecare's value of 94.45% is 657.4% above this benchmark. Historically, Jeena Sikho Lifecare's own ROC (Joel Greenblatt) % has ranged from 39.30 to 134.70 over the past decade. While the company's 10-year median is 67.49 vs. the industry median of 12.47, Jeena Sikho Lifecare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.47, based on 670 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jeena Sikho Lifecare's current ROC (Joel Greenblatt) % of 94.45% is 657.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Jeena Sikho Lifecare and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jeena Sikho Lifecare's current ROC (Joel Greenblatt) % is 94.45%, which is 40% above median its own 10-year median of 67.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeena Sikho Lifecare stock overvalued right now?
Based on GuruFocus' analysis, Jeena Sikho Lifecare (NSE:JSLL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹771.54, compared to a current price of ₹602.25 — trading 21.9% below its estimated fair value. The current ROC (Joel Greenblatt) % is 94.45%, which is 40% above median its 10-year median of 67.49 and 657.4% above the Healthcare Providers & Services industry median of 12.47. Jeena Sikho Lifecare's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Jeena Sikho Lifecare (NSE:JSLL), the current ROC (Joel Greenblatt) % is 94.45% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jeena Sikho Lifecare (NSE:JSLL) Overvalued in 2026?

Based on GuruFocus' analysis, Jeena Sikho Lifecare stock appears to be undervalued. The current stock price of ₹602.25 is trading 21.9% below its estimated GF Value™ of ₹771.54. GuruFocus considers Jeena Sikho Lifecare to be Modestly Undervalued.

Key valuation signals for NSE:JSLL:

  • ROC (Joel Greenblatt) %: 94.45% (40% above median its 10-year median of 67.49)
  • GF Value™: ₹771.54 vs. price of ₹602.25 (21.9% below fair value)
  • GF Score™: 91/100 with 3 warning signs
  • Industry Position: 657.4% above the Healthcare Providers & Services median (#64 of 670)

No single metric tells the full story. See the NSE:JSLL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jeena Sikho Lifecare Business Description

Other Exchanges 544476:India
Address Kalgidhar Enclave, SCO 11 First Floor, Mohali, Zirakpur, PB, IND, 140604
Jeena Sikho Lifecare Ltd provides Ayurvedic healthcare products and services. The company operates only in one business segment which is Trading of Ayurvedic Medicines and providing Ayurvedic therapies. The company engages in conducting health check-up camps, and free yoga sessions to make people aware of health problems. It offers a wide range of Ayurvedic products such as Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package, and Shuddhi Divya Sanjeevani-Anti-Viral Package.
91GF Score

Get the complete analysis for NSE:JSLL

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹602.25
Price
₹771.54
GF Value